Kubra Akillioglu

Adana, 01330, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

GLP-1 receptor agonism reduces PTSD-like anxiety and alters amygdala-hippocampal activity patterns in a Chemogenetic mouse model.

GLP-1 receptor agonism reduces PTSD-like anxiety and alters amygdala-hippocampal activity patterns in a Chemogenetic mouse model.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: April 28, 2026

Transforming Growth Factor Beta-1 Alleviates Neurodegeneration by Regulating Aβ42 and VDAC1 Expression in the Temporal Lobe and Cerebellum in an Alzheimer's Disease-Like Model.

Transforming Growth Factor Beta-1 Alleviates Neurodegeneration by Regulating Aβ42 and VDAC1 Expression in the Temporal Lobe and Cerebellum in an Alzheimer's Disease-Like Model.

Journal: Current molecular medicine

Published: April 15, 2026

Notice of Retraction.

Notice of Retraction.

Journal: Anesthesia and analgesia

Published: October 20, 2025

Vitamin D alleviates neurotoxicity induced by propofol anaesthesia in the offspring of mice.

Vitamin D alleviates neurotoxicity induced by propofol anaesthesia in the offspring of mice.

Journal: PloS one

Published: July 30, 2025

Influence of Vitamin D on Sevoflurane-Induced Neurotoxicity in Offspring Mice.

Influence of Vitamin D on Sevoflurane-Induced Neurotoxicity in Offspring Mice.

Journal: Anesthesia and analgesia

Published: June 23, 2025

The effect of caffeine in a model of schizophrenia-like behavior induced by MK-801 in mice.

The effect of caffeine in a model of schizophrenia-like behavior induced by MK-801 in mice.

Journal: Behavioural brain research

Published: December 16, 2024

Effects of TGF-β1 on Aβ-40 and α- β- γ secretase expression in hippocampus and prefrontal cortex in experimental Alzheimer's disease.

Effects of TGF-β1 on Aβ-40 and α- β- γ secretase expression in hippocampus and prefrontal cortex in experimental Alzheimer's disease.

Journal: Behavioural brain research

Published: July 09, 2024

Preparation of nanoparticle and nanoemulsion formulations containing repaglinide and determination of pharmacokinetic parameters in rats.

Preparation of nanoparticle and nanoemulsion formulations containing repaglinide and determination of pharmacokinetic parameters in rats.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: February 26, 2024

Neuroserpin As an Adjuvant Therapy for Hypothermia on Brain Injury in Neonatal Hypoxic-Ischemic Rats.

Neuroserpin As an Adjuvant Therapy for Hypothermia on Brain Injury in Neonatal Hypoxic-Ischemic Rats.

Journal: American journal of perinatology

Published: August 23, 2023

Long-term effect of indomethacin on a rat model of neonatal hypoxia ischemic encephalopathy through behavioral tests.

Long-term effect of indomethacin on a rat model of neonatal hypoxia ischemic encephalopathy through behavioral tests.

Journal: International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience

Published: May 06, 2023

Investigation of the protective effect of long-term exercise on molecular pathways and behaviours in scopolamine induced alzheimer's disease-like condition.

Investigation of the protective effect of long-term exercise on molecular pathways and behaviours in scopolamine induced alzheimer's disease-like condition.

Journal: Brain research

Published: February 16, 2023

GLP-1 agonist Liraglutide prevents MK‑801-induced schizophrenia‑like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice.

GLP-1 agonist Liraglutide prevents MK‑801-induced schizophrenia‑like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice.

Journal: Behavioural brain research

Published: January 02, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026